oxonic acid has been researched along with Peritonitis in 17 studies
Oxonic Acid: Antagonist of urate oxidase.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 7.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "We report two cases of advanced gastric cancer." | 5.38 | [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 5.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 5.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively." | 5.32 | [A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 3.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "We report two cases of advanced gastric cancer." | 1.38 | [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012) |
| "We report two cases of advanced gastric cancer successfully treated with combination S-1 and docetaxel (DOC) therapy." | 1.36 | [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. ( Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K, 2010) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 1.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "The patient was diagnosed with typeIII gastric cancer by gastroendoscopy postoperatively." | 1.35 | [A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa]. ( Itakura, T; Sugimoto, T; Uesaka, K, 2009) |
| "Two unresectable advanced gastric cancer cases with peritoneal metastases were successfully treated by the combination therapy of S-1 and paclitaxel." | 1.35 | [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy]. ( Ando, T; Furuta, R; Goto, H; Ina, K; Kataoka, T; Kayukawa, S; Masaki, A; Nagao, S; Nishio, T, 2009) |
| "The prognosis for advanced pancreatic cancer with peritoneal dissemination is extremely poor, and no effective standard therapy has been established." | 1.35 | [Continuous treatment with S-1, an effective strategy for an older adult with unresectable advanced pancreatic cancer with peritoneal dissemination-a case report]. ( Inaba, K; Konno, H; Okamoto, N, 2009) |
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 1.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively." | 1.32 | [A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003) |
| "Although the prognosis of recurrent gastric cancer with peritoneal dissemination was extremely poor, this case might suggest a possibility that intensive therapies are useful in maintaining the quality of life and improving survival." | 1.32 | [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy]. ( Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Sakita, I; Souma, I; Yoshida, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshizawa, J | 1 |
| Ishizone, S | 1 |
| Ikeyama, M | 1 |
| Nakayama, J | 1 |
| Katayama, K | 1 |
| Nishino, T | 1 |
| Takahashi, Y | 1 |
| Tanaka, T | 1 |
| Okitsu, H | 1 |
| Okitsu, N | 1 |
| Neduka, H | 1 |
| Munemoto, M | 1 |
| Ojima, T | 1 |
| Earashi, M | 1 |
| Fujii, H | 1 |
| Nonomura, A | 1 |
| Nakamura, S | 1 |
| Kimura, S | 1 |
| Kashima, M | 1 |
| Shichijo, K | 1 |
| Yoshida, S | 1 |
| Harada, E | 1 |
| Matsushita, T | 1 |
| Oshima, Y | 1 |
| Tamaki, Y | 1 |
| Horiuchi, N | 1 |
| Takeichi, T | 1 |
| Fujimoto, H | 1 |
| Masuda, K | 1 |
| Iwasaka, N | 1 |
| Shinomiya, S | 1 |
| Sugimoto, T | 1 |
| Itakura, T | 1 |
| Uesaka, K | 1 |
| Watanabe, T | 1 |
| Hirono, H | 1 |
| Hasegawa, K | 1 |
| Soga, K | 1 |
| Shibasaki, K | 1 |
| Yoneoka, Y | 1 |
| Ina, K | 1 |
| Furuta, R | 1 |
| Kataoka, T | 1 |
| Nishio, T | 1 |
| Nagao, S | 1 |
| Kayukawa, S | 1 |
| Masaki, A | 1 |
| Ando, T | 1 |
| Goto, H | 1 |
| Okamoto, N | 1 |
| Inaba, K | 1 |
| Konno, H | 1 |
| Ueno, S | 1 |
| Nakakuma, T | 1 |
| Aramaki, N | 1 |
| Shiozawa, K | 1 |
| Iizuka, M | 1 |
| Kurita, A | 1 |
| Miyauchi, K | 1 |
| Sengoku, N | 1 |
| Kuranami, M | 1 |
| Kubo, H | 1 |
| Kijima, T | 1 |
| Kitahara, M | 1 |
| Tada, K | 1 |
| Miyahara, M | 1 |
| Hasegawa, H | 1 |
| Okumura, K | 1 |
| Tani, S | 1 |
| Shiogai, Y | 1 |
| Kodama, M | 1 |
| Mekata, E | 1 |
| Tan, T | 1 |
| Hatanaka, F | 1 |
| Matsuo, S | 1 |
| Aratake, Y | 1 |
| Uchimura, K | 1 |
| Yokota, M | 1 |
| Sumii, T | 1 |
| Iguchi, H | 1 |
| Funakoshi, A | 1 |
| Hokita, S | 1 |
| Takatori, H | 1 |
| Ishigami, S | 1 |
| Miyazono, F | 1 |
| Maeda, S | 1 |
| Arima, H | 1 |
| Natsugoe, S | 1 |
| Takao, S | 1 |
| Aikou, T | 1 |
| Hamada, N | 1 |
| Nakagawa, A | 1 |
| Ichiki, M | 1 |
| Sai, K | 1 |
| Sugawara, H | 1 |
| Ebisui, C | 1 |
| Souma, I | 1 |
| Hayashi, N | 1 |
| Fukuchi, N | 1 |
| Izawa, H | 1 |
| Yoshida, T | 1 |
| Sakita, I | 1 |
| Hasuike, Y | 1 |
| Fujimoto, T | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Hotokezaka, M | 1 |
| Iwamura, T | 1 |
| Chijiiwa, K | 1 |
| Ohta, H | 1 |
| Doi, T | 1 |
| Kikuchi, S | 1 |
| Sato, Y | 1 |
| Okuda, T | 1 |
| Fujimi, A | 1 |
| Kanisawa, Y | 1 |
| Izumi, K | 1 |
| Kitahara, T | 1 |
1 review available for oxonic acid and Peritonitis
| Article | Year |
|---|---|
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
16 other studies available for oxonic acid and Peritonitis
| Article | Year |
|---|---|
[Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; | 2013 |
[Highly Advanced Gastric Cancer Leading to Immediate Perforation on Day Three of Chemotherapy with S-1 plus Oxaliplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Organoplati | 2016 |
[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Colonic Neoplasms; Colonoscop | 2008 |
[A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastroscopy; Hum | 2009 |
Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Combinations; F | 2009 |
[Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[Continuous treatment with S-1, an effective strategy for an older adult with unresectable advanced pancreatic cancer with peritoneal dissemination-a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combi | 2009 |
[A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antin | 2009 |
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Dihydrouracil Dehydrogenase (NADP); D | 2012 |
[A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Ascites; Drug Administration Schedule; Drug Combina | 2003 |
[A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Di | 2003 |
[Efficacy of TS-1 in patients with peritonitis carcinomatosa from gastric cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedul | 2003 |
[A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined M | 2004 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |